BANK OF MONTREAL /CAN/ - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2022$1,229,000
+1517.1%
13,190
+2135.6%
0.00%
Q1 2021$76,000
-25.5%
5900.0%0.00%
Q4 2020$102,000
+6.2%
5900.0%0.00%
Q3 2020$96,000
+15.7%
5900.0%0.00%
Q2 2020$83,000
+27.7%
5900.0%0.00%
Q1 2020$65,000
-77.0%
590
-70.8%
0.00%
Q4 2019$282,000
+41.7%
2,024
-2.1%
0.00%
Q3 2019$199,000
-14.6%
2,067
+2.1%
0.00%
Q2 2019$233,000
-41.8%
2,024
-40.4%
0.00%
Q1 2019$400,000
+93.2%
3,396
+2.7%
0.00%
Q4 2018$207,000
-11.5%
3,3080.0%0.00%
Q3 2018$234,000
+6.4%
3,3080.0%0.00%
Q2 2018$220,000
+1.9%
3,3080.0%0.00%
Q1 2018$216,000
+31.7%
3,308
-19.3%
0.00%
Q4 2017$164,000
+10.1%
4,0980.0%0.00%
Q3 2017$149,000
+18.3%
4,098
-9.6%
0.00%
Q2 2017$126,000
+125.0%
4,535
+127.4%
0.00%
Q1 2017$56,0001,9940.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders